«Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway». Nigerian Journal of Physiological Sciences, вип. 40, вип. 2, Грудень 2025, с. 251-62, https://doi.org/10.54548/.